Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL222953 | 1.00 | LMNA (0.67) | LMNAALDH1A1HSD17B10FFAR3LCK | |
| Acetic Acid SCHEMBL8529879 | 0.97 | LMNA (0.63) | LMNAALDH1A1HSD17B10FFAR3LCK | |
| Acetic Acid SCHEMBL7064477 | 0.95 | LMNA (0.60) | LMNAALDH1A1HSD17B10FFAR3LCK | |
| Acetic Acid SCHEMBL4211515 | 0.93 | LMNA (0.57) | LMNAALDH1A1HSD17B10FFAR3LCK | |
| Bicarbonate SCHEMBL5374586 | 0.92 | LMNA (0.71) | LMNAALDH1A1HSD17B10FFAR3THRB | |
| Bicarbonate SCHEMBL28895866 | 0.92 | LMNA (0.71) | LMNAALDH1A1HSD17B10FFAR3THRB | |
| Acetone SCHEMBL590699 | 0.92 | LMNA (0.71) | LMNAALDH1A1HSD17B10THRBTDP1 | |
| Bicarbonate SCHEMBL28942687 | 0.92 | LMNA (0.71) | LMNAALDH1A1HSD17B10FFAR3THRB | |
| Pyruvate SCHEMBL1893245 | 0.90 | LMNA (0.60) | LMNAALDH1A1HSD17B10FFAR3THRB | |
| Butanedione SCHEMBL4368674 | 0.89 | LMNA (0.67) | LMNAALDH1A1HSD17B10THRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317058-A1 | DEGRADABLE POLYMERS AND MONOMERS THEREFOR | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317058-A1 | DEGRADABLE POLYMERS AND MONOMERS THEREFOR | HDHD5, LTA4H, KYNU | LMNA 443/4885ALDH1A1 168/4885HSD17B10 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.